Accelerating metabolic research
Agilent Technologies and Stemina Biomarker Discovery have announced that Agilent will be providing a liquid chromatography system and quadrupole time-of-flight mass spectrometer to accelerate Stemina's metobolomic research.
Agilent Technologies and Stemina Biomarker Discovery have announced that Agilent will be providing a liquid chromatography system and quadrupole time-of-flight mass spectrometer to accelerate Stemina's metobolomic research. The research team uses metabolomic analysis of stem cells for the discovery of biomarkers for use in drug screening and drug development. Software will also be supplied to help researchers interpret the complex data generated by metabolomics experiments.
"We are pleased to broaden our relationship with Agilent to advance our scientific platform and our discovery of important small molecules involved in developmental toxicity and autism," said Beth Donley, Stemina CEO.
"Metabolomics is a major growth area for us, and the innovative work being done at Stemina is the kind we like to support," said Gustavo Salem, Agilent vice president and general manager, Biological Systems Division. "We've aggressively built an LC–MS portfolio for the life sciences in recent years, and the software provides the crucial ability to visualize biological pathways from the massive and complex data sets generated by metabolomics studies."
For more information on the research company visit www.stemina.com
More information on the products is available at www.agilent.com
HPLC 2025 Preview: The Present and Future of Automation in Analytical Laboratories
May 22nd 2025Analytical laboratories are undergoing a fundamental transformation. In the face of increasing sample volumes, growing regulatory requirements, and the rising demand for faster, more precise, and cost-efficient analysis, optimizing laboratory processes is becoming a central focus. Automation technologies offer promising solutions in this regard. Recently, they have evolved from isolated solutions to comprehensive systems that permeate nearly all areas of laboratory practice. This development not only opens up new opportunities in terms of efficiency, data quality, and scalability but also brings technical, organizational, and personnel challenges. To successfully address these, strategic approaches are needed that consider both the technological and human dimensions of the transformation.
Quantifying Isavuconazole in Dried Blood Spots Using HPLC
May 21st 2025Isavuconazole, an antimycotic agent used to treat fungal infections, can typically be found during dried blood spot sampling. However, there are obstacles that keep it from being an ideal approach for properly determining the drug’s presence.
Separating and Quantifying Spinach Flavonoids with UHPLC–MS/MS
May 21st 2025Researchers at Baylor College of Medicine’s Children's Nutrition Research Center (Houston, Texas) developed and validated a high-throughput extraction and ultrahigh-performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) method to separate and quantify 39 spinach flavonoid species in 11.5 min.
